Market revenue in 2023 | USD 2,050.9 million |
Market revenue in 2030 | USD 3,783.0 million |
Growth rate | 9.1% (CAGR from 2023 to 2030) |
Largest segment | Personalized nutrition & wellness |
Fastest growing segment | PM Therapeutics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Illumina Inc, Asure Software Inc, Abbott Laboratories, Danaos Corp, Exact Sciences Corp, Danaher Corp, Amgen Inc, Qiagen NV, Exagen Inc Ordinary Shares, Quest Diagnostics Inc, Biogen Inc, Genelux Corp, International Business Machines Corp, Genentech, 23andMe Holding Co Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to personalized medicine market will help companies and investors design strategic landscapes.
Personalized nutrition & wellness was the largest segment with a revenue share of 35.58% in 2023. Horizon Databook has segmented the UAE personalized medicine market based on pm diagnostics, pm therapeutics, personalized medical care, personalized nutrition & wellness covering the revenue growth of each sub-segment from 2018 to 2030.
Several favorable strategic initiatives have been undertaken in the country. Early screening as well as spreading awareness about precision medicine is expected to play a prominent role in the growth of UAE personalized medicine market during the forecast period.
Moreover, presence of market players is also estimated to accelerate the market growth in the country. In September 2023, the Dubai government announced its plan to provide insurance reimbursement for the Biomerica EZ Detect colorectal disease screening test. Such government support is likely to boost the overall diagnostics and screening for colorectal cancer in the UAE.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE personalized medicine market , including forecasts for subscribers. This country databook contains high-level insights into UAE personalized medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account